The intragastric balloons global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Intragastric Balloons Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The intragastric balloons market size has grown rapidly in recent years. It will grow from $17.85 billion in 2023 to $19.89 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to growing obesity rates, rising healthcare expenditure, clinical evidence and FDA approvals, awareness campaigns, improved balloon designs, growing medical tourism.
The intragastric balloons market size is expected to see rapid growth in the next few years. It will grow to $30.75 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to celebrity endorsements, obesity-related health issues, expansion in emerging markets, an increase in endoscopic procedures, an aging population, and personalized treatment approaches. Major trends in the forecast period include technological innovations, awareness through social media, integration with digital health platforms, artificial intelligence, virtual consultations, and enhanced patient education programs.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report
Scope Of Intragastric Balloons Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Intragastric Balloons Market Overview
Market Drivers –
The increasing obesity rates are expected to propel the growth of the intragastric balloon market going forward. Obesity rates refer to the prevalence or percentage of a population that is considered obese based on body mass index (BMI) measurements, which is generally defined as having a BMI of 30 or higher. The increasing obesity rates are due to dietary habits, sedentary lifestyles, economic factors, advertising and marketing, genetics and biology, psychological and emotional factors, and urbanization and infrastructure. Obese individuals utilize intragastric balloons as a non-surgical option to aid in weight loss by occupying space in the stomach, promoting feelings of fullness, and reducing food intake. For instance, in May 2023, according to a report published by the Office for Health Improvement & Disparities, a UK-based government agency, in 2021–2022, 25.9% of adults aged 18 years and over in England were estimated to be living with obesity. This was an increase from 2020 to 2021 (25.2%). Therefore, the increasing obesity rates are driving the growth of the intragastric balloon market.
Market Trends –
Major companies operating in the intragastric balloon market are focusing on developing advancements in medical weight-loss devices such as swallowable gastric balloons, to enhance patient comfort, ease of use, and accessibility. Swallowable gastric balloons are non-surgical devices that help with weight loss by temporarily occupying space in the stomach, promoting a feeling of fullness, and reducing food intake. For instance, in September 2022, Allurion Technologies Inc., a US-based medical device company, launched a swallowable gastric balloon capsule in India. This is the world’s first non-surgical swallowable gastric balloon that does not require endoscopy or anesthesia for placement or removal. The Allurion gastric balloon capsule offers a safe, non-surgical, and effective weight loss solution to help individuals achieve significant weight loss and adopt healthier lifestyle habits for long-term success.
The intragastric balloons market covered in this report is segmented –
1) By Type: Single, Dual, Triple Intragastric Balloons
2) By Filling Material: Saline Filled, Gas Filled
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies
4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Get an inside scoop of the intragastric balloons market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp
Regional Insights –
North America was the largest region in the intragastric balloons market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd, American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc. , Inamed Health, Medsil , Obalon Therapeutics Inc., Endalis, Lexel SRL
Table of Contents
1. Executive Summary
2. Intragastric Balloons Market Report Structure
3. Intragastric Balloons Market Trends And Strategies
4. Intragastric Balloons Market – Macro Economic Scenario
5. Global Intragastric Balloons Market Size and Growth
.
.
.
32. Global Intragastric Balloons Market Competitive Benchmarking
33. Global Intragastric Balloons Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intragastric Balloons Market
35. Intragastric Balloons Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
